More Articles Back to Article

FDA program to share patient-reported outcomes in cancer drug trials

The FDA has announced a pilot program called Project Patient Voice that will allow drug companies to share information on patient-reported symptoms during clinical trials for cancer drugs. The program will feature a public website, which will contain information on patient symptoms from before the start of treatment and during the first six months of the trial, offering side effect insights not currently available in the FDA safety tables. Bloomberg Law (free content) (6/24)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!